Gainers
- TFF Pharmaceuticals (NASDAQ:TFFP) stock moved upwards by 27.9% to $2.63 during Friday's pre-market session. The market value of their outstanding shares is at $9.1 million.
- Centene (NYSE:CNC) shares increased by 12.62% to $69.4. The market value of their outstanding shares is at $36.5 billion. As per the press release, Q3 earnings came out today.
- Nexalin Technology (NASDAQ:NXL) shares rose 9.31% to $2.35. The company's market cap stands at $24.8 million.
- Citius Oncology (NASDAQ:CTOR) stock rose 8.76% to $1.31. The company's market cap stands at $93.4 million.
- Actinium Pharma (AMEX:ATNM) stock moved upwards by 8.33% to $1.82. The company's market cap stands at $56.7 million.
- BioVie (NASDAQ:BIVI) stock increased by 8.11% to $2.93. The company's market cap stands at $23.3 million.
Losers
- Monopar Therapeutics (NASDAQ:MNPR) shares declined by 23.9% to $24.85 during Friday's pre-market session. The market value of their outstanding shares is at $87.4 million.
- Quince Therapeutics (NASDAQ:QNCX) stock fell 15.97% to $1.0. The company's market cap stands at $43.2 million.
- Bionomics (NASDAQ:BNOX) stock decreased by 14.89% to $0.31. The company's market cap stands at $4.0 million.
- Hepion Pharmaceuticals (NASDAQ:HEPA) shares declined by 11.01% to $0.65. The market value of their outstanding shares is at $3.7 million.
- Dogwood Therapeutics (NASDAQ:DWTX) stock declined by 10.11% to $4.27. The company's market cap stands at $5.6 million.
- Passage Bio (NASDAQ:PASG) shares declined by 9.91% to $0.58. The company's market cap stands at $35.8 million.
This article was generated by Benzinga's automated content engine and reviewed by an editor.
